In a Phase 3 trial hydromethylthionine, a medication for mild-to-moderate Alzheimer's disease, was found to reduce the rate of brain atrophy and reduce cognitive decline by 85% at a surprisingly low dose. It counters tau pathology. BUT, concurrent use of symptom control Alzheimer's medications impaired its effectiveness.

Hydromethylthionine could slow cognitive decline: Minimum dose

"... the additional results of this analysis have given us the confidence ... to confirm the potential efficacy of the hydromethylthionine 16 mg/day dose in these types of patients," said Prof. Claude Wischik,...

image source

Views: 30

Reply to This

About

line

Update Your Membership :

Membership

line

Nexus on Social Media:

© 2020   Atheist Nexus. All rights reserved. Admin: The Nexus Group.   Powered by

Badges  |  Report an Issue  |  Terms of Service